Platelet tyrosine and catecholamine (CA) content was measured in cluster headache sufferers during the different phases of the illness. Compared with controls, cluster headache sufferers had lower platelet levels of norepinephrine (NE) and epinephrine (E) in all phases of the syndrome. Tyrosine levels were increased significantly during the cluster headache attack. We suggest that these results provide biochemical evidence of sympathetic nervous system (SNS) hypofimction in cluster headache. Norepinephrine and epinephrine assay procedure Subjects were resting in a supine position in a quiet room when blood samples were drawn.
The potentials for detector 1, detector 2 and the conditioning cell were + 0 05,-0 -30 and + 0 40 V respectively. (An ESA HR-80 column was used for the separation). The mobile phase consisted of 0 0575 M monobasic sodium phosphate, 1 25 mM heptanesulphonic acid and 0-215 mM EDTA, adjusted to pH 3-6 with phosphoric acid and combined with 3% HPLC grade methanol. A 50 ,ul sample was injected directly onto the column. The retention times for NE and E were 1 9 and 3-1 minutes respectively. Dihydroxybenzylamine was used as an internal standard.
Tyrosine assay procedure Blood (8 ml) was drawn from subjects who were in the supine position and placed into plastic tubes 1:10 dilution containing citrate (3-8%) as the anticoagulant mixture. Platelet rich plasma (PRP) was obtained after the centrifugation of blood at 165 g for 15 minutes. Platelets were counted using a platelet analyser BAKER-810. One ml of PRP was centrifuged at 2500 g for 15 minutes to obtain the platelet pellet. The pellet was resuspended in 1 ml of saline solution, with 30 mg of sulfosalicylic acid added to deproteinise plate- 
Results
There were no significant differences in platelet tyrosine levels (nm/ 10 10 platelet) between control subjects and CH patients in remission or in the cluster period (table 1) . Platelet tyrosine levels were increased significantly during an attack compared with controls and asymptomatic patients in remission or in a cluster period. The results were confirmed in the 12 patients studied sequentially in all phases of the condition [0-17(0-03) attack vs 0-111 (0-07) remission, 0 07 (0 04) cluster period, p = 0 01]. Compared with the control subjects, the mean values of NE and E in the platelet of CH sufferers were significantly lower in all stages of the illness (table 2) . Also, no significant differences were found among groups ofpatients studied at different phases of CH or in eight patients sequentially studied in all phases of the condition. Discussion Platelet catecholamines were low in all stages of CH. We suggest these findings may reflect a generalised systemic state of SNS hypofunction.6 Low platelet CA could be also explained by excessive release during platelet activation.8 Platelet activation is reversed during attacks, however, and release of platelet 5-HT, also contained in dense bodies, is not characteristic of cluster headache. Nevertheless, a normal platelet dense body content must be documented to discount this alternative hypothesis confidently. The normal tyrosine measurements show that substrate deficiency cannot account for low platelet CA levels.
High platelet tyrosine during an attack was unexpected. An increased demand for tyrosine incorporation into structural proteins occurs because of increased protein phosphorylation9 when platelets are activated as in CH patients in remission or in the cluster period outside an attack.8 When during an attack platelet activation is reversed and tyrosine utilisation is correspondingly decreased, platelet levels may become increased transiently until previously enhanced tyrosine synthesis or uptake is downregulated."' This hypothesis and other potential mechanisms require investigation in separate experiments. Table 2 Norepinephrine and epinephrine platelet levels in control subjects and cluster headache patientst 
